A healthtech company that is researching vaccines to combat emerging Covid-19 variants has announced a move to Plymouth Science Park as it grows and takes on global partnerships.
The Vaccine Group (TVG) is a University of Plymouth biotech spin-out company which aims to make the world a safer and healthier place through infection control and vaccine development.
